DIABETES INSIPIDUS. TREATMENT WITH 8-LYSINE VASOPRESSIN IN A NASAL SPRAY.
Synthetic 8-lysine vasopressin administered as a nasal spray to three patients with diabetes insipidus resulted in excellent control in one. In the other two it was of some value as therapy supplemental to pitressin tannate in oil. The patient who was adequately controlled with "spray therapy" alone required the sprays every three hours during the day, but none during the night.
D000336:Aerosols; D001127:Arginine Vasopressin; D003919:Diabetes Insipidus; D020790:Diabetes Insipidus, Neurogenic; D004358:Drug Therapy; D006801:Humans; D008236:Lypressin; D008239:Lysine; D059085:Nasal Sprays; D019999:Pharmaceutical Solutions; D010909:Pituitary Hormones, Posterior; D012138:Respiratory Therapy; D014667:Vasopressins
D000336:Aerosols; D059085:Nasal Sprays; D019999:Pharmaceutical Solutions; D010909:Pituitary Hormones, Posterior; C016671:pitressin tannate; D014667:Vasopressins; D001127:Arginine Vasopressin; D008236:Lypressin; D008239:Lysine
DIABETES INSIPIDUS; DRUG THERAPY; INHALATION THERAPY; LYSINE; PITUITARY HORMONES, POSTERIOR; VASOPRESSIN